Opaleye Management Inc. - Jan 28, 2022 Form 4 Insider Report for HARROW HEALTH, INC. (HROW)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Stock symbol
HROW
Transactions as of
Jan 28, 2022
Transactions value $
$43,686
Form type
4
Date filed
1/31/2022, 03:05 PM
Previous filing
Jan 24, 2022
Next filing
Mar 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HROW Common Stock, par value $0.001 per share Purchase $34.4K +5K +0.16% $6.89 3.14M Jan 28, 2022 By Opaleye, L.P. F1, F3
transaction HROW Common Stock, par value $0.001 per share Purchase $9.25K +1.34K +0.9% $6.89 150K Jan 28, 2022 By Managed Account F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.
F3 The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $6.8873. The range of purchase prices on the transaction date was $6.88 to $6.90 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.